Due to the rapid renal clearance of small peptides like GLP-1, along with its deactivation by dipeptidyl peptidase 4 (DPP4), development of stable peptides, with an increased resistance to DPP4 was required ( The origin of GLP-1 and its physiological pathway was discovered in the 1980s by the decoding of nucleotide sequences of mammalian preproglucagons, the precursors of proglucagon ( When GLP-1 interacts with GLP-1R, this triggers cyclic adenosine monophosphate (cAMP) formation and initiates subsequent pathways ( 2 Methodology A structured literature search was conducted using PubMed/MEDLINE and Google Scholar, with the Boolean search string: (GLP-1 receptor agonist OR GLP-1RA) AND (multifaceted roles OR pleiotropic effects)
Y., & Hsiao, J
The major limiting step to achieving normoglycaemia is hypoglycaemia, which occurs more frequently in the first half of pregnancy, in part because of diminished awareness of hypoglycaemia and pregnancy-associated nausea and vomiting [267]
The compounds that were effective across multiple models were further tested as single agents and in combination with a clinically relevant protocol mimicking COJEC 12 , the five-chemotherapy cocktail (cisplatin, vincristine, carboplatin, etoposide and cyclophosphamide) that is the first line of action to treat HR-NB patients set by the International Society of Pediatric OncologyEuropean Neuroblastoma (SIOPEN) 6